calendar
1,034 catalysts · 3,189 8k filing · 2,025 grant · 1,000 device adverse event · 867 approval · 647 device 510k · 584 earnings
next 91 dayslessmore
MonWedFri
1,034 catalysts · 3,189 8k filing · 2,025 grant · 1,000 device adverse event · 867 approval · 647 device 510k · 584 earnings
no tagged catalysts yet
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ZYDUS LIFESCIENCES. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION
Sponsor: CIPLA. Form: CAPSULE. Route: ORAL
Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL
Sponsor: CMP DEV LLC. Form: SOLUTION. Route: ORAL
Sponsor: GENERAL AIR SERVICE & SUPPLY COMPANY. Form: GAS. Route: INHALATION
Sponsor: NIAGARA PHARMS. Form: SOLUTION. Route: OPHTHALMIC
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL
Sponsor: LONG GROVE PHARMS. Form: GEL, METERED. Route: TRANSDERMAL
Sponsor: CHANGZHOU PHARM. Form: CAPSULE. Route: ORAL
Sponsor: APIL. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ORGANON. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: KINDOS. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL
Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL
Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL
Sponsor: ORBION PHARMS. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL
Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL
Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: QILU PHARM HAINAN. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION
Sponsor: APIL. Form: TABLET. Route: ORAL
Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL
Sponsor: NANG KUANG PHARM CO. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: QILU PHARM HAINAN. Form: INJECTABLE. Route: INTRAVENOUS
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL), Distributed by Haleon, Warren, NJ 07059. NDC 0135-0651-02 — Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles. — Status: Ongoing